MAGN logo

MAGNERA CORP

MAGNNYSE
πŸ† #2523 by market capEarnings Nov 17US Equity
$302.56β–² $6.66 (+2.20%)
Simulated price
1hβ€”
24hβ–² 2.2%
7dβ–² 2134.6%
14dβ–² 2089.3%
30dβ–² 2229.2%
1yβ–² 2142.8%
🏦Market Cap
$446M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+49.3%
High Growth
πŸ“ŠGross Margin
11.3%
Thin
πŸ’΅FCF Margin
4.7%
Moderate
βš–οΈP/S Ratio
0.1x
Cheap
Otter Score
56
Weak

Trading Snapshot

Day Range
$301.20 – $304.33
52-Week Range
$7.82 – $15.52
Volume
$2.57B
Avg Volume
$2.45B
Shares Outstanding
35.8M
Next Earnings
Sep 25, 2026

Fundamentals Snapshot

Annual Revenue
$3.20B
Last Q Revenue
$857M
P/E Ratio
β€”
P/S Ratio
0.1x
EPS (TTM)
$-3.09
Dividend Yield
β€”

Why Investors Own MAGN

  • βœ“High-growth profile β€” revenue up +0.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 80% gross margin and 16% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$3.20Bβ–Ό βˆ’3.1% YoY
Gross Margin (TTM)
80.0%β–² +0.3% YoY
Operating Income (TTM)
$1.21Bβ–Ό βˆ’3.1% YoY
Free Cash Flow (TTM)
$522Mβ–Ό βˆ’3.1% YoY

About MAGNERA CORP

Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence. The company also offers tea bags, coffee filters, wipes, cable wrap, filtration, baby diapers and adult incontinence. The company is headquartered in Charlotte, North Carolina.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$359.32
β–² +18.8% Upside
High Target$413.27
Low Target$328.17
Based on 41 analysts

Latest News & Updates